ZY [NASD]
Zymergen Inc.
Index- P/E- EPS (ttm)-9.53 Insider Own4.10% Shs Outstand102.92M Perf Week-6.62%
Market Cap113.37M Forward P/E- EPS next Y-2.55 Insider Trans-2.10% Shs Float93.03M Perf Month-36.82%
Income-361.80M PEG- EPS next Q-0.71 Inst Own70.40% Short Float5.16% Perf Quarter-68.72%
Sales16.70M P/S6.79 EPS this Y-82.10% Inst Trans0.94% Short Ratio4.16 Perf Half Y-86.87%
Book/sh3.97 P/B0.32 EPS next Y65.20% ROA-68.30% Target Price3.38 Perf Year-96.46%
Cash/sh4.33 P/C0.29 EPS next 5Y- ROE-226.80% 52W Range1.28 - 46.05 Perf YTD-81.02%
Dividend- P/FCF- EPS past 5Y- ROI-76.80% 52W High-97.24% Beta-
Dividend %- Quick Ratio5.50 Sales past 5Y- Gross Margin- 52W Low-0.78% ATR0.22
Employees507 Current Ratio5.50 Sales Q/Q-49.20% Oper. Margin- RSI (14)34.20 Volatility16.28% 13.63%
OptionableYes Debt/Eq0.11 EPS Q/Q1.60% Profit Margin- Rel Volume1.25 Prev Close1.42
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume1.15M Price1.27
Recom3.40 SMA20-22.96% SMA50-47.03% SMA200-82.91% Volume1,431,028 Change-10.56%
Mar-02-22Resumed Cowen Market Perform
Jan-12-22Upgrade HSBC Securities Reduce → Hold $6.50
Oct-15-21Resumed Cowen Market Perform
Sep-27-21Downgrade JP Morgan Neutral → Underweight $12
Aug-31-21Downgrade UBS Buy → Neutral $56 → $13
Aug-04-21Downgrade William Blair Outperform → Mkt Perform
Aug-04-21Downgrade JP Morgan Overweight → Neutral $12
Aug-04-21Downgrade HSBC Securities Hold → Reduce $8
Aug-04-21Downgrade Goldman Buy → Neutral $55 → $12
Aug-04-21Downgrade Cowen Outperform → Market Perform
Aug-04-21Downgrade BofA Securities Buy → Underperform $43 → $7
Jul-06-21Initiated HSBC Securities Hold $42
Jun-29-21Initiated William Blair Outperform
May-17-21Initiated JP Morgan Overweight $40
May-17-21Initiated Goldman Buy $55
May-17-21Initiated Cowen Outperform
May-17-21Initiated BofA Securities Buy $43
May-13-22 01:30AM  
May-12-22 05:55PM  
04:05PM  
May-05-22 03:00PM  
Apr-29-22 08:00AM  
Apr-20-22 12:58PM  
Apr-13-22 04:05PM  
Mar-22-22 09:00PM  
04:05PM  
Mar-16-22 04:05PM  
Mar-07-22 06:20AM  
Mar-06-22 07:00PM  
Feb-28-22 08:00AM  
Feb-22-22 09:03AM  
Jan-10-22 08:17PM  
Jan-09-22 09:00PM  
Jan-05-22 04:05PM  
Dec-22-21 04:41PM  
Dec-20-21 07:05AM  
Dec-15-21 09:00PM  
Dec-03-21 09:00PM  
Nov-25-21 03:34PM  
Nov-22-21 11:57AM  
Nov-18-21 11:48AM  
Nov-11-21 12:00PM  
Nov-10-21 05:31PM  
11:24AM  
Nov-08-21 12:45PM  
Nov-04-21 03:01AM  
Nov-03-21 05:25PM  
04:05PM  
Oct-26-21 04:05PM  
Oct-21-21 05:44PM  
Oct-19-21 02:19PM  
Oct-18-21 12:12PM  
Oct-04-21 02:35PM  
01:29PM  
12:35PM  
12:15PM  
11:08AM  
10:55AM  
10:00AM  
09:40AM  
08:44AM  
07:37AM  
05:26AM  
Oct-03-21 11:45PM  
08:00PM  
06:41PM  
12:00PM  
11:11AM  
08:51AM  
08:51AM  
Oct-02-21 06:00PM  
10:35AM  
10:02AM  
Oct-01-21 10:50PM  
08:35PM  
08:00PM  
07:00PM  
06:30PM  
04:30PM  
03:15PM  
03:10PM  
02:21PM  
01:55PM  
12:35PM  
12:15PM  
12:00PM  
11:59AM  
11:00AM  
10:00AM  
09:52AM  
07:45AM  
Sep-30-21 11:53PM  
11:15PM  
10:30PM  
08:00PM  
06:27PM  
03:08PM  
01:41PM  
01:15PM  
11:40AM  
11:34AM  
11:00AM  
09:51AM  
08:15AM  
07:10AM  
05:44AM  
Sep-29-21 10:23PM  
09:50PM  
07:43PM  
06:15PM  
06:00PM  
04:40PM  
04:10PM  
04:00PM  
02:40PM  
01:10PM  
11:30AM  
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kim MinaChief Legal OfficerMay 02Sale1.793,2065,740310,794May 04 06:17 PM
Serber ZachariahChief Science OfficerMay 02Sale1.793,0825,5182,568,963May 04 06:26 PM
Kimball AaronChief Technology OfficerApr 01Sale2.8732,63993,551712,644Apr 05 05:15 PM
Kimball AaronChief Technology OfficerMar 01Sale3.8125,00095,345745,283Mar 03 06:33 PM
Serber ZachariahChief Science OfficerFeb 22Sale3.911,4245,5682,373,491Feb 24 04:53 PM
Serber ZachariahChief Science OfficerFeb 14Sale4.005,43521,7302,374,915Feb 16 05:45 PM
Serber ZachariahChief Science OfficerFeb 07Sale4.335,43523,5292,380,350Feb 09 06:54 PM
Kimball AaronChief Technology OfficerFeb 01Sale5.0625,000126,605770,283Feb 03 06:15 PM
Serber ZachariahChief Science OfficerJan 31Sale5.035,43527,3592,385,785Feb 02 06:03 PM
Serber ZachariahChief Science OfficerJan 24Sale4.7621,730103,4462,391,220Jan 26 05:54 PM
Kimball AaronChief Technology OfficerJan 18Sale5.1850,000259,080795,283Jan 20 05:42 PM
Singh EnakshiChief Financial OfficerDec 28Option Exercise1.7050,00085,000227,000Dec 30 04:52 PM
FLATLEY JAY TChairman and Acting CEONov 17Buy10.00100,0001,000,000144,789Nov 19 04:30 PM
Kimball AaronChief Technology OfficerOct 06Option Exercise4.479,00040,230765,283Oct 07 05:10 PM